Donepezil (Aricept®, Eisai Co. Ltd., Tokyo, Japan), a type of cholinesterase inhibitors (ChEIs), is the world's first drug, approved for dementia with Lewy bodies (DLB) in September 2014 in Japan. Here, BCHE is linked to Lewy body dementia.